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S.A.AR86 and Girdwood S.A., two South African Sindbis-like arboviruses, are closely related antigenically to the Swedish
isolate, Ockelbo82 [Lundstro¨m, J. O., Vene, S., Saluzzo, J. F., and Niklasson, B. (1993) Am. J. Trop. Med. Hyg. 49(5), 531–
537]. Each of these viruses is associated with human disease, and Girdwood S.A. was isolated from a human case. In
addition, S.A.AR86 is unique among Sindbis-like viruses in that adult mice remain sensitive to lethal infection with S.A.AR86.
The complete genomic sequences of S.A.AR86 and Girdwood S.A. were determined. The S.A.AR86 RNA genome contained
11,663 nucleotides, excluding the 5* CAP structure and 3* poly(A) tail. In comparison to the consensus sequence of the
prototype Egyptian Sindbis strain AR339, S.A.AR86 differed at 5.57% of the nucleotides, including a 54-nucleotide deletion,
two insertions of 6 nucleotides each, and a 3-nucleotide insertion in the 3* terminal one-third of the S.A.AR86 nsP3 gene.
S.A.AR86 is one of only three alphaviruses sequenced to date that does not have an opal termination codon between the
nsP3 and the nsP4 genes. These genes are separated by a cysteine codon in the S.A.AR86 genome. The genome of
Girdwood S.A. was 11,717 nucleotides in length, excluding the 5* CAP and 3* poly(A) tail. Girdwood S.A. contained an opal
termination codon between nsP3 and nsP4 and did not have the large 54-nucleotide deletion in nsP3, although Girdwood
S.A. did contain the remaining insertions and deletions characteristic of S.A.AR86. S.A.AR86 was more closely related to
Girdwood S.A. than to the Egyptian isolate, and the South African isolates as a group were more closely related to the
Swedish isolate. Comparison of the S.A.AR86 sequence to that of Ockelbo82, Girdwood S.A., and Sindbis virus AR339
revealed several codons where S.A.AR86 differed from the conserved amino acid encoded by the other three viruses. These
changes may be related to the ability of S.A.AR86 to initiate a lethal central nervous system infection in adult mice. To fulfill
a prerequisite for testing this hypothesis, a full-length cDNA clone of S.A.AR86 was constructed from which infectious
genomic RNA replicas could be derived. The sequence of this clone differed from the S.A.AR86 genomic RNA sequence
at four translationally silent positions, and virus derived from the clone reproduced the adult mouse neurovirulence phenotype
of its biological progenitor. q 1996 Academic Press, Inc.
Sindbis virus, the prototype member of the alphavirus recovered from a pool of Culex sp. mosquitoes collected
in Sindbis, Egypt in 1953 (9) and is the most extensivelygenus of the family Togaviridae, and viruses closely re-
studied representative of this group. Natural isolates as-lated to Sindbis are broadly distributed throughout Africa,
sociated with human disease include S.A.AR86, Ock-Europe, Asia, the Indian subcontinent, and Australia,
elbo82, and Girdwood S.A. These ‘‘Sindbis-like’’ virusesbased on serological surveys of humans, domestic ani-
are related to Sindbis strain AR339 but are more closelymals, and wild birds (1 –6). Sequence comparisons of
related to each other based on serological comparisonsSindbis with a South American alphavirus, Aura, and with
(10). S.A.AR86 was isolated in 1954 from a pool of Culexthe structural gene region of western equine encephalitis
sp. mosquitoes collected near Johannesburg, South Af-virus (WEE) suggest that Sindbis-like viruses also exist
rica during an arbovirus survey (11) and was temporallyin the Western hemisphere (7, 8).
associated with a febrile illness in humans (2, 12) similarThe first isolate of Sindbis virus (strain AR339) was
to that caused by Ockelbo82 (13). Ockelbo82 was iso-
lated from Culiseta sp. mosquitoes collected in Edsbyn,1 The nucleotide sequence data reported in this paper have been
Sweden in 1982 and was associated serologically withsubmitted to the GenBank nucleotide sequence database and have
been assigned the Accession Nos. U38304 (Girdwood S.A.) and U38305 human disease (14). Girdwood S.A. was isolated from a
(S.A.AR86). human patient in the Johannesburg area of South Africa
2 Present address: Centers for Disease Control and Prevention, 1600 in 1963 (15) and has the distinction of being one of the
Clifton Road, Atlanta, GA 30333
few Sindbis isolates derived from a human case.3 Present address: Washington and Lee University, Department of
The clinical symptoms of human infection with Ock-Biology, Parmly Hall, Room 306, Lexington, VA 24450
4 To whom reprint requests should be addressed. Fax: (919) 962-8103. elbo82, S.A.AR86, or Girdwood S.A. are a febrile illness,
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general malaise, macropapular rash, and joint pain 5256 to 5311 of AR339. As a result of these deletions
and insertions, S.A.AR86 nsP3 was 13 amino acidswhich occasionally progresses to a polyarthralgia some-
times lasting from a few months to a few years. The smaller than in AR339, containing an 18-amino-acid dele-
tion and a total of 5 amino acids inserted. The 3* untrans-pathogenesis underlying this human disease is not
known. Experimental infections with strain AR339 and its lated region of S.A.AR86 contained, with respect to
AR339, two 1-nucleotide deletions at nucleotides 11,513laboratory derivatives have explored Sindbis virus viru-
lence and pathogenesis in the mouse model. In new- and 11,602, and one 1-nucleotide insertion following nu-
cleotide 11,664. The total numbers of nucleotides andborns of this animal host, inocula approaching a single
plaque-forming unit (PFU) administered either subcuta- predicted amino acids comprising the remaining genes
of S.A.AR86 were identical to those of AR339.neously (sc) or intracranially (ic) produce a uniformly fatal
disease characterized by high levels of viral replication A notable feature of the deduced amino acid sequence
of S.A.AR86 was the cysteine codon in place of an opalin the brain. However, in mice greater than 2 weeks of
age, all natural isolates of Sindbis virus examined to termination codon between nsP3 and nsP4. S.A.AR86 is the
only Sindbis virus isolate, and one of just three alphavirusdate, with the exception of S.A.AR86, are avirulent even
when injected ic at high doses and even though virus isolates sequenced to date, which do not contain an opal
termination codon between nsP3 and nsP4 (25, 26).replicates in the central nervous system (CNS) to high
titers (16, 17). S.A.AR86, however, retains neurovirulence The genome of Girdwood S.A. was 11,717 nucleotides
long excluding the 5* CAP and 3* poly(A) tail. The extrafor mice regardless of age, inducing uniformly fatal infec-
tion after ic inoculation of doses less than that detectable nucleotides relative to AR339 were in the nonconserved
half of nsP3, which contained insertions totalling 15 nu-by standard plaque assay in baby hamster kidney (BHK-
21) cells (18). cleotides, and in the 3* untranslated region which con-
tained two 1-nucleotide deletions and a 1-nucleotide in-Therefore, S.A.AR86 presents an intriguing opportunity
to investigate a Sindbis-like virus associated with human sertion with respect to the consensus Sindbis AR339
genome. The insertions found in the nsP3 gene of Gird-disease as well as the mechanism by which S.A.AR86
overcomes the age-related restriction characteristic of wood S.A. were identical in position and content to those
found in S.A.AR86, although Girdwood S.A. did not haveother Sindbis and Sindbis-like viruses. In the experi-
ments reported here, the first objective was to determine the large nsP3 deletion characteristic of S.A.AR86. The
remaining portions of the genome contained the samethe complete genomic sequences of S.A.AR86 and Gird-
wood S.A., and to compare these to each other and number of nucleotides and predicted amino acids as
Sindbis AR339. Overall, Girdwood S.A. was 94.5% identi-closely related Sindbis-like viruses, thus identifying
amino acid differences potentially associated with the cal to the consensus Sindbis AR339 sequence, differing
at 655 nucleotides not including the insertions and dele-unique neurovirulence phenotype of S.A.AR86. The sec-
ond objective was to construct a full-length cDNA clone tions. These nucleotide differences resulted in 88 pre-
dicted amino acid changes or a difference of 2.3%. Aof the S.A.AR86 genome such that the virus derived from
it would reproduce the adult mouse neurovirulence phe- plurality of amino acid differences were concentrated in
the nsP3 gene, which contained 32 of the amino acidnotype of the natural isolate. This clone will provide a
stable system to examine the molecular genetics of changes, 25 of which were in the nonconserved 3* half.
We were unable to resolve the Girdwood S.A. nucleotidesS.A.AR86 pathogenesis.
The sequences of S.A.AR86 and Girdwood S.A. were at positions 1, 3, and 11,717. Because the primer used
during the RT-PCR amplification of the 3* end of the ge-determined from uncloned RT-PCR fragments amplified
from virion RNA (19). The sequence of the 5* 40 nucleo- nome assumed a cytosine in the 3* terminal position (5*-
CTAACGGCTCGAGTCTAGAT25G-3*), we were unable totides was determined by directly sequencing the geno-
mic RNA (20 – 22). The S.A.AR86 genome was 11,663 nu- determine with certainty the identity of this nucleotide.
However, in all alphaviruses sequenced to date there iscleotides in length, excluding the 5* CAP and 3* poly(A)
tail, 40 nucleotides shorter than the prototype Sindbis a cytosine in this position. This, combined with the fact
that no difficulty was encountered in obtaining an RT-strain AR339 (23). Compared with the consensus se-
quence of Sindbis virus AR339 (24), S.A.AR86 contained PCR product for this region with an oligo(dT) primer end-
ing with a 3* G, suggested that Girdwood S.A. also con-two separate 6-nucleotide insertions, and one 3-nucleo-
tide insertion in the 3* half of the nsP3 gene, a region tained a cytosine at this position. The ambiguity at nucle-
otide positions 1 and 3 resulted from strong stops en-not well conserved among alphaviruses. The two 6-nu-
cleotide insertions were found immediately 3* of nucleo- countered during the RNA sequencing.
Table 1 examines the relationship of S.A.AR86 andtides 5403 and 5450, and the 3-nucleotide insertion was
immediately 3* of nucleotide 5546 compared with the Girdwood S.A. to each other and to other Sindbis-related
viruses. This was accomplished by aligning the nucleo-AR339 genome. In addition, S.A.AR86 contained a 54-
nucleotide deletion in nsP3 which spanned nucleotides tide and deduced amino acid sequences of Ockelbo82,
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TABLE 1
Differences between Sindbis AR339, OCKELBO82, and Girdwood S.A. Viruses with Respect to S.A.AR86 Virus
Nucleotidesa Amino acidsa
AR339 OCK82 GIRD AR339 OCK82 GIRD
Regions Number (%) Number (%)
5* untranslated 0 (0.0) 0 (0.0) 1 (1.7) — — —
nsP1 76 (4.7) 37 (2.3) 15 (0.9) 9 (1.7) 6 (1.1) 2 (0.4)
nsP2 137 (5.7) 86 (3.6) 45 (1.9) 15 (1.9) 8 (1.0) 12 (1.5)
nsP3
Conservedb 51 (5.7) 35 (3.9 13 (1.6) 6 (2.0) 1 (0.3) 1 (0.4)
Nonconservedc 116 (6.6) 83 (4.4) 70 (2.2) 45 (9.7) 34 (7.0) 27 (3.7)
nsP4 111 (6.1) 68 (3.7) 19 (1.1) 8 (1.3) 2 (0.3) 4 (0.6)
26s junction 1 (2.1) 0 (0.0) 1 (2.1) — — —
Capsid 36 (4.5) 26 (3.3) 7 (0.9) 1 (0.4) 3 (1.1) 0 (0.0)
E3 17 (8.9) 5 (2.6) 4 (2.1) 1 (1.6) 0 (0.0) 0 (0.0)
E2 71 (5.6) 43 (3.4) 18 (1.4) 12 (2.6) 6 (1.4) 2 (0.5)
6K 10 (6.1) 9 (5.4) 4 (2.4) 2 (3.6) 2 (3.6) 1 (1.8)
E1 49 (3.7) 31 (2.3) 16 (1.2) 7 (1.6) 6 (1.4) 2 (0.9)
3* untranslated 14 (4.5) 8 (2.5) 1 (0.3) — — —
Totals 689 (5.5) 431 (3.3) 214 (1.4) 106 (2.3) 68 (1.4) 51 (0.9)
Note. All nucleotide positions and gene boundaries are numbered according to that used for the Sindbis AR339, HRSP variant (Genebank Accession
No. J02363; (23)) unless otherwise noted. These comparisons utilized the deduced Sindbis AR339 sequence (24).
a Differences include insertions and deletions.
b Conserved region nucleotides 4100 to 5000 (aa1 to aa300).
c Nonconserved region nucleotides 5001 to 5729 (aa301 to aa542, S.A.AR86 numbering).
AR339, and Girdwood S.A. to those of S.A.AR86 and then neurovirulence phenotype of S.A.AR86, a full-length
cDNA clone of the S.A.AR86 genome was constructed.calculating the percentage identity for each gene using
The sources of cDNA included conventional cDNAthe programs contained within the Wisconsin GCG pack-
clones (28) as well as uncloned RT-PCR fragments de-age (27). The analysis suggests that S.A.AR86 is most
rived from the S.A.AR86 genome. As illustrated in Fig. 1,similar to the other South African isolate, Girdwood S.A.,
these were substituted, starting at the 3* end, intoand that the South African isolates are more similar to the
Swedish Ockelbo82 isolate than to the Egyptian Sindbis
AR339 isolate. These results also suggest that it is un- TABLE 2
likely that S.A.AR86 is a recombinant virus like western
S.A.AR86 Amino Acids Potentially Related to the Adult
equine encephalitis virus (7). Neurovirulence Phenotype
Since Girdwood S.A., Ockelbo82, and S.A.AR86 were
S.A.AR86 Conservedso closely related by sequence, we confirmed that only
Positiona amino acid amino acidS.A.AR86 displayed the adult mouse neurovirulence phe-
notype. Groups of four female CD-1 mice (3–6 weeks of
nsP1 583 Thr Ile
age) were inoculated ic with 103 PFU of S.A.AR86, Gird- nsP2 256 Arg Ala
wood S.A., or Ockelbo82. Neither Girdwood S.A. nor Ock- 648 Ile Val
651 Lys Gluelbo82 infection produced any clinical signs of infection.
nsP3 344 Gly GluIn contrast, infection with S.A.AR86 produced neurologi-
386b Tyr Sercal signs within 4 to 5 days and ultimately killed 100%
441 Asp Gly
of the mice as previously demonstrated (18). 445 Ile Met
Table 2 lists those amino acids of S.A.AR86 which 537 Cys Opal
E2 243 Ser Leumight explain its neurovirulence phenotype in adult mice.
6K 30 Val IleWe scored a position as potentially related to the
E1 112 Val AlaS.A.AR86 adult neurovirulence phenotype if the S.A.AR86
169 Leu Ser
amino acid differed from that which otherwise was abso-
lutely conserved at that position in the other viruses. a S.A.AR86 numbering.
b Last amino acid before 18-amino-acid deletion found in S.A.AR86.As a first step in investigating the unique adult mouse
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FIG. 1. Construction of full-length S.A.AR86 cDNA clones and chimeric AR339/S.A.AR86 clones. Clones were constructed by substituting S.A.AR86
specific cDNA’s (j) for the analogous regions in pTR5000 (h). Substitutions proceeded in both 3* and 5* directions. Viability was measured as
specific infectivity of RNA transcripts derived from the clones. Virus derived from a clone was considered viable if the PFU/cpm of 35S-UTP-labeled
transcripts was greater than 10% of the PFU/cpm of 35S-UTP-labeled transcripts derived from pTR5000 (25).
pTR5000 (24), a full-length Sindbis clone from which in- nsP3 to the BstBI site in nsP4. The remaining pTR5000
sequences were replaced with S.A.AR86 sequences byfectious genomic replicas could be derived by transcrip-
tion with SP6 polymerase in vitro. The viability of the replacing the AgeI (nsP2) to BstBI (nsP4) region of clone
pS21 with a corresponding S.A.AR86 cDNA clone. Tran-chimeric clones was tested by comparing the specific
infectivities (19, 24) of the transcripts from each clone scripts derived from this clone (pS22) were infectious,
although the resulting virus was temperature-sensitive,with that of transcripts derived from pTR5000. Transcripts
from chimeric clones extending from the 3* end of the exhibiting a three to four log reduction in titer at 377 as
compared to the titer of virus grown at 297 (data notgenome into the 3* half of the nsP4 gene (clones pS1,
pS3.1, and pS5.1) were infectious, whereas replacement shown). We repeated the replacement of the AgeI to
BstBI region using a different primary S.A.AR86 cDNAof additional nsP4 sequence to the HindIII site with
S.A.AR86 sequences rendered the resulting transcripts clone to construct clone pS24, which corrected the tem-
perature-sensitive defect.noninfectious (clone pS6.1). The loss of viability was not
due to defective sequence in the HindIII to KpnI fragment, Unlike the S.A.AR86 biological isolate, virus derived from
pS24 failed to display a neurovirulent phenotype upon icbecause the same sequence is a constituent of viable
full-length S.A.AR86 clones pS22, pS24, and pS55. Rather inoculation of adult mice. Therefore, the nucleotide se-
quence of pS24 was determined by direct sequencing ofthis suggested that not all of the pTR5000 and S.A.AR86
nonstructural proteins may be compatible with each the clone itself or by sequencing subclones used during
its construction. Comparison of the pS24 sequence to theother and/or that individual chimeric nonstructural pro-
teins may not be functional. However, viable transcripts genomic RNA sequence of S.A.AR86 revealed several cod-
ing and silent nucleotide differences. The coding differ-were produced from clone pS13, which contained
S.A.AR86 gene sequences from the 5* end of the genome ences were repaired by replacing the mutated regions with
analogous uncloned RT-PCR fragments generated frominto the 3* half of the nsP1 gene and from the AatII site
in capsid to the 3* end of the genome. Noninfectious S.A.AR86 virion RNA. The end result was pS55, a clone
from which infectious transcripts could be produced andtranscripts were derived from pS14 and pS21, the latter
having pTR5000 sequences only from the SalI site in which contained four nucleotide changes (G for A at nt 215;
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FIG. 2. Virus growth of S.A.AR86 and S55 in vivo. S.A.AR86 and S55 titers in the brain and serum of 25-day-old female CD-1 mice inoculated ic
with 103 PFU of virus were compared. Each bar represents a single animal at each time point. The line in panels B and D represents the minimum
level of detection at each time point. (A) S.A.AR86 brain titers; (B) S.A.AR86 serum titers; (C) S55 brain titers; (D) S55 serum titers.
G for C at nt 3863; G for A at nt 5984; and C for T at nt From these data we conclude that the silent changes
found in virus derived from clone pS55 had little or no9113) but no amino acid differences with respect to the
S.A.AR86 genomic RNA. effect on its growth or virulence, and that this molecularly
cloned virus accurately represents the biological isolate,To determine if virus derived from pS55 (S55) repro-
duced the defining adult neurovirulence characteristic of S.A.AR86.
S.A.AR86, the virulence phenotype and replication of S55
were compared to S.A.AR86 in adult (25-day-old) female
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